Understanding how pancreatic cells adapt in diabetes
Mechanisms of islet compensation for β-cell mass deficiency in diabetes
This study is looking at how certain cells in the pancreas adjust when there aren’t enough insulin-producing cells in people with type 2 diabetes, and it aims to understand how these changes might help keep blood sugar levels in check.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11048847 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which pancreatic alpha-cells adapt to the loss of beta-cell mass in type 2 diabetes. It explores how increased secretion of glucagon from alpha-cells may help maintain insulin secretion and regulate blood sugar levels. Using a novel mouse model that lacks the ability for beta-cells to replicate, the study examines the interactions between different cell types in the pancreas and their roles in glycemic control. Advanced techniques like single-cell RNA sequencing will be employed to analyze changes in cell function and communication.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes who may benefit from improved insulin regulation.
Not a fit: Patients with type 1 diabetes or those without any form of diabetes may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance insulin secretion in diabetes patients.
How similar studies have performed: Previous studies have shown promising results in understanding pancreatic cell interactions, but this specific approach is novel and aims to uncover new mechanisms.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Merrins, Matthew J. — Yale University
- Study coordinator: Merrins, Matthew J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.